CeriBell, Inc. (CBLL) vs Savara Inc. (SVRA)

A side-by-side comparison of CeriBell, Inc. and Savara Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CBLL

CeriBell, Inc.

$934M

$24.62HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT

SVRA

Savara Inc.

$955M

$4.66HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT

Total return — CBLL vs SVRA

growth of $100 · dividends reinvested · last 2y

CBLL -0.6% (-0.3%/yr)SVRA +32.8% (+15.2%/yr)SVRA compounded faster over this window

CBLL SVRA

CBLL vs SVRA: by the numbers

•SVRA is the larger company ($955M vs $934M market cap).
•Both run net losses; SVRA's is the smaller (0.00% vs -64.73% net margin).

Metrics side by side

Valuation

Metric	CBLL	SVRA
P/S ratio	9.16	N/A
P/B ratio	7.28	6.65

Profitability

Metric	CBLL	SVRA
Gross margin	88.90%	0.00%
Operating margin	-68.62%	0.00%
Net margin	-64.73%	0.00%
ROE	-51.43%	-96.97%
ROIC	-46.54%	-82.30%

Growth (annualized)

Metric	CBLL	SVRA
Total return CAGR (5Y)	N/A	29.75%

Go deeper

Full CBLL analysis Full SVRA analysis Interactive comparison tool

Dig into the metrics

CeriBell ROE Savara ROE CeriBell operating margin Savara operating margin CeriBell revenue growth Savara revenue growth CeriBell free cash flow Savara free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.